Bivalirudin for Injection, a direct thrombin inhibitor, expands the company's anticoagulant portfolio.
November 15, 2016
Paris, France
Bryan, Garnier & Co. Healthcare Conference
Quarterly Financial Report Q3 2016 (US-GAAP)
November 03, 2016
Bad Homburg, Germany
Quarterly Financial Report Q3 2016 (IFRS)
November 01, 2016
Bad Homburg, Germany